Alabama-headquartered BC Platforms and Switzerland-based Proteus Genomics have set out to speed up the development of precision medicine by streamlining the integration of genomic and health care data. The two companies aim to reduce the number of deaths in the US caused by adverse reactions to medication, the country's fourth highest cause of death which costs $3.5bn annually. By combining pharmacology and genomics information, clinicians can develop safe medicines tailored to patients' specific needs.
Switzerland-headquartered BC Platforms and Alabama-based Proteus Genomics have set out to speed up the development of precision medicine by streamlining the integration of genomic and health care data. The two companies aim to reduce the number of deaths in the US caused by adverse reactions to medication, the country's fourth highest cause of death which costs $3.5bn annually. By combining pharmacology and genomics information, clinicians can develop safe medicines tailored to patients' specific needs.